Zoltan Csimma, senior vice president and chief human resources officer, Genzyme
Dale Cumming, director of scientific evaluations, International Consortium on Anti-Virals
Tim Cunningham, senior manufacturing supervisor, Biolex
Rosemarie Currier, contract administrator, EnerNOC [Added: 6:40 pm Eastern, 9/27/10]
Klaus Dahl, retired [Added: 2 pm, 4/2/10]
Stan Daley, retired [Added: 12:30 pm, 3/29/10]
Karen Dawes, president, Knowledgeable Decisions. Board member, Repligen and Depomed
Dawn Day, manager, sales systems and reporting, Novartis Vaccines & Diagnostics
Charlene (Quinto) DeClercq, senior research scientist, inflammation & immunology, Pfizer. [Added: 9:35 am, 1/24/11]
Tom DesRosier, senior vice president and general counsel, Genzyme
Andrew Dorner, senior director, Millennium: The Takeda Oncology Company
Deb Donaldson, translational medicine specialist in the San Francisco Bay Area
Eileen Dube, owner, Merrimack Valley Acupuncture
Kevin Dykstra, president and CEO, qPharmetra [Updated: 11:05 am, 9/30/10]
Jeff Eckman, CEO, BlueGreen Ventures
John Edwards, president, Adnexus Therapeutics
Bruce Eisen, retired [Added:10:10 am ET, 8/9/11]
Bonnie Fendrock, president and CEO, Hepregen
Crystal Ferguson, executive coordinator, corporate communications, Millennium: The Takeda Oncology Company [Added: 2 pm, 3/29/10]
John Fernberg, director of operations, Biogen Idec
Charles (Chuck) Finn, co-founder, president and CEO, RRD International
Lori Fitz, principal research scientist, inflammation and immunology, Pfizer [Added: 11:15 am, 6/2/10]
Bill Fleming, IT senior engineer, regional client computing, Pfizer [Added: 12:05 am, 4/2/10]
Barry Foster, retired [Added: 6:40 pm, 7/23/10]
Lynette Fouser, Principal Research Scientist II, Pfizer [Added: 9:35 pm 11/21/10]
Ed Fritsch, consultant
L. Patrick Gage, founder, enGage Biotech Consulting; executive chairman, Virdante Pharmaceuticals; board member, Acceleron Pharma, Immune Control, and Alvine Pharmaceuticals. Chairman of Cytokinetics. [Updated: 9:45 pm, 3/22/10]
Marc Garnick, clinical professor, Harvard Medical School
Derick Gates, senior director, global CMC, Pfizer [Added: 11:59 pm, 3/30/10]
Jack Geissert, Director EHS Pfizer, retired 2017
Jill Goddard, associate Director, clinical operations, Infinity Pharmaceuticals [Added: 9:45 pm, 3/22/10]
Jane Davis Golden, director, clinical development, Virdante Pharmaceuticals [Added: 10:05 am, 3/23/10]
Jennifer Sydney Goldman, director, clinical business operations, Aveo Pharmaceuticals [Added: 9:45 pm Eastern, 3/22/10]
David Graham, vice president of program and alliance management, Aveo Pharmaceuticals
George Green, head of global manufacturing, technology development, Novartis Vaccines and Diagnostics
Scott Greer, managing director, Numenor Ventures, founder of Abgenix
Nick Guise, consultant, CNG Consultants
Tuan Ha-Ngoc, CEO, Aveo Pharmaceuticals
Alan Harris, executive director & global franchise head neuroscience and ophthalmology, Novartis Biologics
Dana Helm, independent human resources consultant
Rod Hewick, retired
Geoffrey Hodge, vice president of process development and technology, Xcellerex
Brian Hubbard, scientific executive director, Amgen
Tina Hurley, director, product development, Biogen Idec [Added: 10:40 am, 5/20/10]
Ben Isaacs, co-founder and president, Formatech
Indu Isaacs, co-founder and CEO, Formatech
Mary Antoinette Jackson, manager, global information services, Vertex Pharmaceuticals [Added: 3:35 pm, 10/19/11]
Ken Jacobs, director of project management, ImmunoGen
